How Will the Buccal Drug Delivery System Market Grow? Key Trends and Opportunities for 2025 and Beyond
Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!
What key factors are powering the surge in the buccal drug delivery system market right now?
The market size of the buccal drug delivery system has seen swift expansion in the last few years. It is projected to increase from $3.55 billion in 2024 to $3.91 billion in 2025, with a compound annual growth rate (CAGR) of 10.3%. The significant growth during the historic period can be credited to initial innovations in drug delivery, the pharmaceutical industry’s acceptance, clinical studies and effectiveness, strategic penetration into the market, and targeted applications for specific diseases.
How fast Is the buccal drug delivery system market expected to grow, and what’s its future value?
In the coming years, a swift expansion is predicted for the buccal drug delivery system market, with its worth expected to reach $5.97 billion in 2029, exhibiting a compound annual growth rate (CAGR) of 11.1%. This anticipated growth during the forecast period could be attributed to factors such as patient-oriented drug administration, an increase in the elderly population, the requirement for targeted treatments, the delivery of biologics and peptides, regulatory backing and approvals, as well as r&d investments. The period is also set to witness trends like higher patient comfort and adherence, advancements in drug designs, increasing chronic diseases, the focus on pediatric and geriatric health care, and improved drug bioavailability.
Get your buccal drug delivery system market report here!
https://www.thebusinessresearchcompany.com/report/buccal-drug-delivery-system-global-market-report
What are the leading drivers of growth in the buccal drug delivery system market?
An increase in chronic diseases is predicted to fuel the expansion of the buccal drug delivery systems market. Chronic diseases are long-term health conditions lasting a year or more, including ailments like cancer, heart disease, stroke, diabetes, and arthritis. These common chronic illnesses require ongoing medication and nutritional care, though they cannot be fully cured. Buccal drug delivery systems offer suitable and effective drug delivery for offering mucosal and transmucosal drugs needed by many patients battling chronic illnesses, such as diabetes and cancer. For example, the World Health Organization, a United Nations specialized agency based in Switzerland, reported in September 2023 that there were 41 million fatalities, forming 74% of the annual global deaths due to non-communicable diseases (NCDs) or chronic diseases. Cardiovascular diseases took 17.9 million lives, cancer claimed 9.3 million lives, chronic respiratory diseases caused 4.1 million deaths, and diabetes led to 2.0 million deaths. As such, the escalating prevalence of chronic illnesses is the main driver behind the growing buccal drug delivery systems market.
What are the key segments defining the buccal drug delivery system market?
The buccal drug delivery system market covered in this report is segmented –
1) By Type: Sublingual, Buccal Tablets And Lozenges, Oral Sprays
2) By Application: Pain Management, Smoking Cessation, Angina Pectoris
3) By End-User: Hospitals, Ambulatory Centers, Other End-Users
Subsegments:
1) By Sublingual: Sublingual Tablets, Sublingual Films
2) By Buccal Tablets And Lozenges: Buccal Tablets, Buccal Lozenges
3) By Oral Sprays: Spray Solutions, Spray Gels
Get your free sample now – explore exclusive market insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=8290&type=smp
Who are the key players steering the development of the buccal drug delivery system market?
Major companies operating in the buccal drug delivery system market are Teva Pharmaceuticals Industries Ltd., Pfizer Incorporated, GlaxoSmithKline Public Limited Company, Indivior PLC, Generex Biotechnology Corporation, Catalent Inc., Arx Limited Liability Company, BioDelivery Science International Incorporated, Cynapsus Therapeutics Incorporated, Endo Pharmaceuticals Public Limited Company, Medlab Clinical Ltd., AstraZeneca PLC, F Hoffmann-La Roche Limited, Dr. Reddy’s Laboratories Ltd., Takeda Pharmaceutical Company Limited, Novartis AG, Novo Nordisk A/S, Ethypharm SAS, Applied Pharma Research SA, Sunovion Pharmaceuticals Inc., Sanofi SA, Bayer AG, Adare Pharmaceuticals Inc., NAPP Pharmaceutical Ltd., Perrigo Company PLC, Reckitt Benckiser Group PLC, Teligent Pharma Inc., Par Pharmaceutical Companies Inc., Acorda Therapeutics Inc., Opiant Pharmaceuticals Inc.
What emerging trends are influencing the growth of the buccal drug delivery system market?
Leading firms within the buccal drug delivery systems market, like Bristol Myers Squibb, are concentrating their efforts on the creation of novel solutions, including oral medications intended for the treatment of plaque psoriasis. Plaque psoriasis oral treatments are medication consumed orally to manage and relieve a long-term immunological disorder symptoms, where abnormal skin cell growth leads to thick, red, and scaly patches. For example, in September 2022, the US-based pharmaceutical company, Bristol Myers Squibb, got approval from the FDA for using Sotyktu (deucravacitinib), an oral therapy for adults suffering from moderate-to-severe plaque psoriasis. This green light signals the first approval of a new oral treatment for this condition in roughly ten years, offering a unique method of action as a selective inhibitor of tyrosine kinase 2 (TYK2).
Unlock exclusive market insights – purchase your research report now for a swift delivery!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=8290
Which regions are most influential in expanding the buccal drug delivery system market?
North America was the largest region in the buccal drug delivery systems market share in 2024. The regions covered in the buccal drug delivery system market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Browse Through More Similar Reports By The Business Research Company:
Implantable Drug Delivery Devices Global Market Report 2024
Injectable Drug Delivery Devices Global Market Report 2024
Drug Delivery Devices Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/drug-delivery-devices-global-market-report
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
